Patents Assigned to SNIPR TECHNOLOGIES LIMITED
-
Publication number: 20200390886Abstract: The invention relates to methods of modulating immune cells in a patient by altering microbiota of the patient. The invention also relates to methods of modulating treatments or therapies in a subject organism by altering microbiota of the subject. The invention also relates to cell populations, systems, arrays, cells, RNA, kits and other means for effecting this. In an example, advantageously selective targeting of a particular species in a human gut microbiota using guided nucleic acid modification is carried out to effect the alteration.Type: ApplicationFiled: August 27, 2020Publication date: December 17, 2020Applicant: SNIPR Technologies LimitedInventor: Jasper CLUBE
-
Publication number: 20200337313Abstract: The invention relates to methods, uses, systems, arrays, engineered nucleotide sequences and vectors for inhibiting bacterial population growth or for altering the relative ratio of sub-populations of first and second bacteria in a mixed population of bacteria. The invention is particularly useful, for example, for treatment of microbes such as for environmental, medical, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system.Type: ApplicationFiled: March 9, 2020Publication date: October 29, 2020Applicant: SNIPR Technologies LimitedInventors: Jasper CLUBE, Morten SOMMER, Christian GRØNDAHL, Eric VAN DER HELM, Ruben VAZQUEZ-URIBE
-
Patent number: 10765740Abstract: The invention relates to methods of modulating immune cells in a patient by altering microbiota of the patient. The invention also relates to methods of modulating treatments or therapies in a subject organism by altering microbiota of the subject. The invention also relates to cell populations, systems, arrays, cells, RNA, kits and other means for effecting this. In an example, advantageously selective targeting of a particular species in a human gut microbiota using guided nucleic acid modification is carried out to effect the alteration.Type: GrantFiled: October 4, 2019Date of Patent: September 8, 2020Assignee: SNIPR Technologies LimitedInventor: Jasper Clube
-
Publication number: 20200267992Abstract: The invention relates to methods, uses, systems, arrays, engineered nucleotide sequences and vectors for inhibiting bacterial population growth or for altering the relative ratio of sub-populations of first and second bacteria in a mixed population of bacteria. The invention is particularly useful, for example, for treatment of microbes such as for environmental, medical, food and beverage use The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system.Type: ApplicationFiled: April 24, 2020Publication date: August 27, 2020Applicant: SNIPR Technologies LimitedInventor: Jasper CLUBE
-
Patent number: 10751427Abstract: The invention relates to retrieving or modifying target nucleic acids, such as host cell chromosomal DNA, by homologous recombination with vectors that contain homology arms flanked by nuclease cutting sites that have been cut by a nuclease such as Cas to provide recombinogenic nucleic acid strands in situ. The methods described herein can be used in genetic engineering of cells and for gene therapy of cells or organisms.Type: GrantFiled: June 27, 2018Date of Patent: August 25, 2020Assignee: SNIPR TECHNOLOGIES LIMITEDInventor: Jasper Clube
-
Publication number: 20200164070Abstract: The invention relates to methods of modulating immune cells in a patient by altering microbiota of the patient. The invention also relates to methods of modulating treatments or therapies in a subject organism by altering microbiota of the subject. The invention also relates to cell populations, systems, arrays, cells, RNA, kits and other means for effecting this. In an example, advantageously selective targeting of a particular species in a human gut microbiota using guided nucleic acid modification is carried out to effect the alteration.Type: ApplicationFiled: February 7, 2020Publication date: May 28, 2020Applicant: SNIPR Technologies LimitedInventor: Jasper CLUBE
-
Publication number: 20200128832Abstract: The invention relates to methods, uses, systems, arrays, engineered nucleotide sequences and vectors for inhibiting bacterial population growth or for altering the relative ratio of sub-populations of first and second bacteria in a mixed population of bacteria. The invention is particularly useful, for example, for treatment of microbes such as for environmental, medical, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system.Type: ApplicationFiled: January 8, 2020Publication date: April 30, 2020Applicant: SNIPR Technologies LimitedInventors: Jasper CLUBE, Morten SOMMER, Christian GRØNDAHL, Eric VAN DER HELM, Ruben VAZQUEZ-URIBE
-
Publication number: 20200121787Abstract: The invention relates to methods of modulating immune cells in a patient by altering microbiota of the patient. The invention also relates to methods of modulating treatments or therapies in a subject organism by altering microbiota of the subject. The invention also relates to cell populations, systems, arrays, cells, RNA, kits and other means for effecting this. In an example, advantageously selective targeting of a particular species in a human gut microbiota using guided nucleic acid modification is carried out to effect the alteration.Type: ApplicationFiled: January 7, 2020Publication date: April 23, 2020Applicant: SNIPR Technologies LimitedInventor: Jasper CLUBE
-
Patent number: 10624349Abstract: The invention relates to methods, uses, systems, arrays, engineered nucleotide sequences and vectors for inhibiting bacterial population growth or for altering the relative ratio of sub-populations of first and second bacteria in a mixed population of bacteria. The invention is particularly useful, for example, for treatment of microbes such as for environmental, medical, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system.Type: GrantFiled: November 17, 2017Date of Patent: April 21, 2020Assignee: SNIPR TECHNOLOGIES LIMITEDInventor: Jasper Clube
-
Patent number: 10603379Abstract: The invention relates to methods of modulating immune cells in a patient by altering microbiota of the patient. The invention also relates to methods of modulating treatments or therapies in a subject organism by altering microbiota of the subject. The invention also relates to cell populations, systems, arrays, cells, RNA, kits and other means for effecting this. In an example, advantageously selective targeting of a particular species in a human gut microbiota using guided nucleic acid modification is carried out to effect the alteration.Type: GrantFiled: June 26, 2019Date of Patent: March 31, 2020Assignee: SNIPR Technologies LimitedInventors: Jasper Clube, Morten Sommer, Christian Grøndahl
-
Patent number: 10596255Abstract: The invention relates to methods of modulating immune cells in a patient by altering microbiota of the patient. The invention also relates to methods of modulating treatments or therapies in a subject organism by altering microbiota of the subject. The invention also relates to cell populations, systems, arrays, cells, RNA, kits and other means for effecting this. In an example, advantageously selective targeting of a particular species in a human gut microbiota using guided nucleic acid modification is carried out to effect the alteration.Type: GrantFiled: April 19, 2019Date of Patent: March 24, 2020Assignee: SNIPR Technologies LimitedInventor: Jasper Clube
-
Publication number: 20200077663Abstract: The invention relates to methods, uses, systems, arrays, engineered nucleotide sequences and vectors for inhibiting bacterial population growth or for altering the relative ratio of sub-populations of first and second bacteria in a mixed population of bacteria. The invention is particularly useful, for example, for treatment of microbes such as for environmental, medical, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system.Type: ApplicationFiled: September 30, 2019Publication date: March 12, 2020Applicant: SNIPR Technologies LimitedInventors: Jasper CLUBE, Morten SOMMER, Christian GRØNDAHL, Eric VAN DER HELM, Ruben VAZQUEZ-URIBE
-
Patent number: 10582712Abstract: The invention relates to methods, uses, systems, arrays, engineered nucleotide sequences and vectors for inhibiting bacterial population growth or for altering the relative ratio of sub-populations of first and second bacteria in a mixed population of bacteria. The invention is particularly useful, for example, for treatment of microbes such as for environmental, medical, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system.Type: GrantFiled: March 16, 2017Date of Patent: March 10, 2020Assignee: SNIPR TECHNOLOGIES LIMITEDInventors: Jasper Clube, Morten Sommer, Christian Grøndahl, Eric Van Der Helm, Ruben Vazquez-Uribe
-
Publication number: 20200068901Abstract: The invention relates to methods, uses, systems, arrays, engineered nucleotide sequences and vectors for inhibiting bacterial population growth or for altering the relative ratio of sub-populations of first and second bacteria in a mixed population of bacteria. The invention is particularly useful, for example, for treatment of microbes such as for environmental, medical, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system.Type: ApplicationFiled: September 30, 2019Publication date: March 5, 2020Applicant: SNIPR Technologies LimitedInventors: Jasper CLUBE, Morten SOMMER, Christian GRØNDAHL, Eric VAN DER HELM, Ruben VAZQUEZ-URIBE
-
Patent number: 10561148Abstract: The invention relates to methods, uses, systems, arrays, engineered nucleotide sequences and vectors for inhibiting bacterial population growth or for altering the relative ratio of sub-populations of first and second bacteria in a mixed population of bacteria. The invention is particularly useful, for example, for treatment of microbes such as for environmental, medical, food and beverage use. The invention relates inter alia to methods of controlling micro biologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system.Type: GrantFiled: November 15, 2018Date of Patent: February 18, 2020Assignee: SNIPR Technologies LimitedInventor: Jasper Clube
-
Publication number: 20200030444Abstract: The invention relates to methods of modulating immune cells in a patient by altering microbiota of the patient. The invention also relates to methods of modulating treatments or therapies in a subject organism by altering microbiota of the subject. The invention also relates to cell populations, systems, arrays, cells, RNA, kits and other means for effecting this. In an example, advantageously selective targeting of a particular species in a human gut microbiota using guided nucleic acid modification is carried out to effect the alteration.Type: ApplicationFiled: October 4, 2019Publication date: January 30, 2020Applicant: SNIPR Technologies LimitedInventor: Jasper CLUBE
-
Patent number: 10524477Abstract: The invention relates to methods, uses, systems, arrays, engineered nucleotide sequences and vectors for inhibiting bacterial population growth or for altering the relative ratio of sub-populations of first and second bacteria in a mixed population of bacteria. The invention is particularly useful, for example, for treatment of microbes such as for environmental, medical, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system.Type: GrantFiled: November 17, 2017Date of Patent: January 7, 2020Assignee: SNIPR TECHNOLOGIES LIMITEDInventors: Jasper Clube, Morten Sommer, Christian Grøndahl, Eric Van Der Helm, Ruben Vazquez-Uribe
-
Patent number: 10506812Abstract: The invention relates to methods, uses, systems, arrays, engineered nucleotide sequences and vectors for inhibiting bacterial population growth or for altering the relative ratio of sub-populations of first and second bacteria in a mixed population of bacteria. The invention is particularly useful, for example, for treatment of microbes such as for environmental, medical, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system.Type: GrantFiled: November 17, 2017Date of Patent: December 17, 2019Assignee: SNIPR TECHNOLOGIES LIMITEDInventor: Jasper Clube
-
Patent number: 10463049Abstract: The invention relates to methods, uses, systems, arrays, engineered nucleotide sequences and vectors for inhibiting bacterial population growth or for altering the relative ratio of sub-populations of first and second bacteria in a mixed population of bacteria. The invention is particularly useful, for example, for treatment of microbes such as for environmental, medical, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system.Type: GrantFiled: November 17, 2017Date of Patent: November 5, 2019Assignee: SNIPR TECHNOLOGIES LIMITEDInventors: Jasper Clube, Morten Sommer, Christian Grøndahl, Eric Van Der Helm, Ruben Vazquez-Uribe
-
Publication number: 20190321469Abstract: The invention relates to methods of modulating immune cells in a patient by altering microbiota of the patient. The invention also relates to methods of modulating treatments or therapies in a subject organism by altering microbiota of the subject. The invention also relates to cell populations, systems, arrays, cells, RNA, kits and other means for effecting this. In an example, advantageously selective targeting of a particular species in a human gut microbiota using guided nucleic acid modification is carried out to effect the alteration.Type: ApplicationFiled: June 26, 2019Publication date: October 24, 2019Applicant: SNIPR Technologies LimitedInventors: Jasper CLUBE, Christian GRØNDAHL, Morten SOMMER